<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02304900</url>
  </required_header>
  <id_info>
    <org_study_id>PHRI09-PJP / IOL et sommeil</org_study_id>
    <nct_id>NCT02304900</nct_id>
  </id_info>
  <brief_title>Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep</brief_title>
  <acronym>IOL et sommeil</acronym>
  <official_title>Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The cataract surgery (550 000 operations per year in France) is to replace the cloudy lens
      with a refractive implant. Two colors of implants are available: white implants, filtering
      out ultraviolet and yellow implants, filtering and more blue light. No clinical data are
      available to assert the superiority of an implant according to its color and the choice is
      made according to the preference of the surgeon and / or &quot;markets&quot;.

      It is established in humans that blue light has an important role on the secretion of
      melanopsin, a key mediator of the circadian cycle. This &quot;clock&quot; regulates most neuroendocrine
      functions in the nycthémère (sleep, mood, temperature, cortisol, ..). The question of the
      impact of these neuro endocrine functions of the installation of a blue light filter into the
      eyes of patients operated thus arises.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Variation between before and 2 months after surgery sleep time</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Variation between before and 2 months after surgery the number of hours of sleep</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation between before and 2 months after surgery of the quality of sleep</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation between before and 2 months after surgery the mood evaluation score</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Group 1 : white implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomization will determine the color of the implant to be used for each patient for interventions in both eyes, white or yellow to know.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 : yellow implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomization will determine the color of the implant to be used for each patient for interventions in both eyes, white or yellow to know.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>white implant</intervention_name>
    <description>st intervention (in the month following the inclusion): Randomization of the color of the implant
nd operation (1 to 3 months after the first surgery): Installation of a same color as the first implant operated eye</description>
    <arm_group_label>Group 1 : white implant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>yellow implant</intervention_name>
    <description>st intervention (in the month following the inclusion): Randomization of the color of the implant
nd operation (1 to 3 months after the first surgery): Installation of a same color as the first implant operated eye</description>
    <arm_group_label>Group 2 : yellow implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female or male subject

          -  subject between 60 and 90 years old

          -  Visual acuteness &lt; or = with 2 eyes

          -  Indication operating of the cataract

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Service d'Ophtalmologie</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service d'Ophtalmologie, Centre Hospitalier Paul Martinais</name>
      <address>
        <city>Loches</city>
        <zip>37600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service d'Ophtalmologie</name>
      <address>
        <city>Tours</city>
        <zip>37</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2014</study_first_submitted>
  <study_first_submitted_qc>November 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2014</study_first_posted>
  <last_update_submitted>February 23, 2017</last_update_submitted>
  <last_update_submitted_qc>February 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cataract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

